Efficacy and Immunogenicity of Single-Dose AdVAV Intranasal Anthrax Vaccine Compared to Anthrax Vaccine Absorbed in an Aerosolized Spore Rabbit Challenge Model

AdVAV is a replication-deficient adenovirus type 5-vectored vaccine expressing the 83-kDa protective antigen (PA83) from Bacillus anthracis that is being developed for the prevention of disease caused by inhalation of aerosolized B. anthracis spores. A noninferiority study comparing the efficacy of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Vaccine Immunol
Autors principals: Krishnan, Vyjayanthi, Andersen, Bo H., Shoemaker, Christine, Sivko, Gloria S., Tordoff, Kevin P., Stark, Gregory V., Zhang, Jianfeng, Feng, Tsungwei, Duchars, Matthew, Roberts, M. Scot
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4375354/
https://ncbi.nlm.nih.gov/pubmed/25673303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00690-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars